Integer Holdings Co. (NYSE:ITGR) Receives $147.67 Consensus Target Price from Analysts

Shares of Integer Holdings Co. (NYSE:ITGR) have received an average recommendation of “Moderate Buy” from the eight ratings firms that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $149.00.

ITGR has been the topic of several recent analyst reports. KeyCorp boosted their target price on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Benchmark boosted their price target on shares of Integer from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, February 21st. Wells Fargo & Company reissued an “overweight” rating and issued a $160.00 price target on shares of Integer in a research note on Tuesday, December 3rd. Oppenheimer downgraded shares of Integer from an “outperform” rating to a “market perform” rating in a research note on Friday, February 21st. Finally, Truist Financial boosted their price target on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th.

Hedge Funds Weigh In On Integer

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Integer in the fourth quarter valued at approximately $7,889,000. Brucke Financial Inc. purchased a new stake in shares of Integer in the 4th quarter valued at approximately $564,000. Azzad Asset Management Inc. ADV raised its holdings in shares of Integer by 4.9% in the 4th quarter. Azzad Asset Management Inc. ADV now owns 12,138 shares of the medical equipment provider’s stock valued at $1,609,000 after purchasing an additional 566 shares in the last quarter. Vise Technologies Inc. raised its holdings in shares of Integer by 8.3% in the 4th quarter. Vise Technologies Inc. now owns 4,702 shares of the medical equipment provider’s stock valued at $623,000 after purchasing an additional 362 shares in the last quarter. Finally, Squarepoint Ops LLC raised its holdings in shares of Integer by 25.7% in the 4th quarter. Squarepoint Ops LLC now owns 3,162 shares of the medical equipment provider’s stock valued at $419,000 after purchasing an additional 646 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Stock Performance

NYSE:ITGR opened at $117.76 on Wednesday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The firm has a market capitalization of $3.96 billion, a price-to-earnings ratio of 35.05, a PEG ratio of 1.72 and a beta of 1.24. The company’s 50-day moving average is $134.11 and its two-hundred day moving average is $132.76. Integer has a 1-year low of $107.11 and a 1-year high of $146.36.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing the consensus estimate of $1.46 by ($0.03). The firm had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a net margin of 6.92% and a return on equity of 11.65%. Analysts forecast that Integer will post 6.01 EPS for the current year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.